Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great Smooth Legend. Some studies going on, smart people being funded to cut through some of the work for CV and potential partner. Specifically to your link, no results, but if this Mr Dustin Clark Lee comes back with positive results from his studies funded at John Hopkins would that not just increase the value of CVSI's patent?
Hey Smooth Legend "I agree, legality is not an issue. It was Monas, and now it’s the share price."
If share price is the issue, release the new products and announce a partnership to develop the patent.
Nice fine Visionario. More added pressure needed.
Also from Mary on the Y board.
So if the R/S was approved, executed and then uplisting did not immediately occur and dropped back below the required $4 would we all be ready to for a shareholder lawsuit?
Well lets plug the new products into their current retail distribution in q3, q4 and q1 2021, so revenues increase to $20Million + a quarter and additionally identify a a strategic partner for 007 and wa-la we would likely be over $2.
Agreed AP17!
Happening NOW White house is reviewing FDA research guidance on CBD. No better grasp on timing for decision, but at least they are still working on the project during these troubling times.
https://www.marijuanamoment.net/the-white-house-is-reviewing-cbd-and-marijuana-research-guidance-from-fda/
Got a CVSI newsletter sent my way. I like any engagement from CV Science. Hopefully this is going to key retailers so they can link it to e-commerce as well. https://view.pluscbd.com/?qs=98dd496f847e548a465ccdbb92fe0a94b6bfc5579e88de0ba410240c1e50883cb1cae7643e6231c0a1038bb9ce9f26869daf4401aa91eb74f67ebeb3e74f1f4f79b58dc33ad17ea3499cd9c791d9bed8
Most likely 1 time payment. Highly doubt any company would consider purchasing the patent with a sales volume base royalty offering to CV Sciences.
We should all be appalled by the notion and proposal of a reverse split for multiple reasons.
We are on a new trajectory with the issue of the patent. If our management can not open their rolodex and reach out to previous potential investors or industry peers to reengage them in discussing personal investments into CVSI, with patent approval, we have the wrong team. Mackay, Dowling, Tomc, Maroon, Mcnulty, Graham, Blake all have +20 years in their field. How about landing some nice PR outlining the patent approval and plans to attract investors.
Other Questions:
Why won't they provide the catalyst for the change of heart from Nasdaq for the approval? What has changed in NASDAQ's mind since we were at $4? Provide that and the RS may make more sense.
Why not wait until 2021 to ask for the split? See how COV-id changes route to markets and get NEW Harvest or whatever line they are going to release in Q3 off and running.
What are their thoughts on Mr. Luck? Surely he has caused many long nights and serious anxiety with the true believers and shareholders of the company.
I'm over Dowling. I want more transparency. He's not convincing and more and more comes off as a slime ball trying to hide too much. Not the right guy for the role. The company has too much potential for him to be the chosen one.
Besides a strategic partner for the patent development the next big opportunity is the roll out of the new product line discussed for Q3. Bigger emphasis on E-commerce for the new line(likely New Harvest) over PLUS could create serious momentum into Q4.
Thank you Belgie24 and SpaceLady!
Hmmm My shares are through Schwab and I never received a notice/ proxy to vote on it.
When and how did the reverse split voting option go out to shareholders? I never received an option to vote unless its voluntary through a website portal of some kind.
Taking all catalyst into consideration and removing the ones we can't control(FDA timing and competition) my interest is more in New Harvest right now to grow revenue more than anything. Q2 will be brutal we get it,so run the skeleton team Dowling and make the larger margins online. Your follower base is low in Social Media so intern a college grad to grow it.
C level team and the board needs to be out there raising interest from serious investors, not talking to retailers and consumers. Leave the ground level communications up to the sales and marketing team.
With New Harvest it sounds like they developed the line with key retailers input(Sprouts?, Cvs?, maybe multiple) and in my experience in CPG and developing brands as a producer along side the retailer the results are very strong. Fingers crossed New Harvest is a banger and branding really pops on the shelf at key price points.
Patent provides an asset, working through the testing will be expensive.
Not sure why Dowling sounded so against a partnership or even an acquisition. At this point I don't think they can tackle all the objectives on their own.
I'll gladly watch this ride down to .20 and accumulate. Most of the downward movement is from COVId and Mona selling off. I'm already in too deep not to average down and put more chips on the table.
They DO NOT NEED the reverse split now, as in 2020.
Get the 6 new skus or new brand line out there and increase sales revenue.
Open up new business internationally.
Wait for FDA update.
See where the COVID outcome pushes the category drivers.
After those catalyst I would "consider" voting yes.
Agree with you 100% motorcity.
Can someone please explain how removing the patent asset and moving it into its own/new C corp will effect the current value of the CVSI stock?
Based on Mike's first question I foresee "New Harvest" making a retail appearance in Q3.
Seems they have so many irons in the fire, S3, 007 Patent, New Harvest TM, awaiting FDA and then potentially NASDAQ. I whole heartedly believe they are doing some major prep work behind the scenes for when the CBD market bust open to the mainstream retailers.
CVSI Long,
CA AB228 updated article.
Hopefully back on track to address.
https://www.bevnet.com/news/2020/in-california-cbd-brands-await-legislative-relief-amidst-local-crackdown
Video of Whole Foods CBD Category buyer stating not touching CBD products until FDA regulation is to their comfort level. Reminder Amazon owns Whole Foods, so this likely goes for Amazon as well. Surely this massive retailer is putting inquires into the FDA often as they are missing out and Kroger is testing the waters.
Fast forward the video to 7:50
[url][/url][tag]i
Brightfield Group Pr with CVSI. Pulled from CVSI Linkedin news page
https://www.greenmarketreport.com/brightfield-group-names-top-5-cbd-companies/
Noted Spacelady and will go with $18,450,000
I'm at 18.3mil. Thanks SpaceLady
Playing all 4 Quarters as well. Told myself until 2 of the catalyst occur I'm staying in. Ranked in no specific order.
1. Lawsuit dismissal
2. Patent Approval
3. FDA clear ruling on Hemp Derived CBD
4. NASDAQ
5. Ingestible Soft Gels at Walgreens/CVS/711/Amazon/Walmart/Costco and/or Target
6. Acquisition
Unless we get industry ending news, which I think is unlikely a few of these are potentially around the corner.
Mark44 where's the link to your reference?
Siglar did not seem integral to the future. His forte was asset management primarily in the real estate sector. Cheers to him and his exit. Make room for a new key player on the board.
Great to see that pic Benjamin Wulf. As for their market up. Most national retailers aim to make 30% on alcohol beverage, but since this is coming warehouse direct I bet they are making 40-50% margin.
Not sure if bulk/quantity deals are legal in pharmaceuticals, but I would think so.
duffy's confidence in the strategy he presented is second to none.
Thanks Sleuth! That is great. I would have gone but had meeting. Next time I'd love the opportunity to meet up with my local Longs here in SD.
Surprised to see Kroger skipped the 101 stores in their California Division, Ralphs and Ralphs Fresh Fare. The California Alcohol Beverage Control recently had all ingestible pulled from Lazy Acres and Bristol Farms leaving only topicals. The reason is they are not allowing outlets that have Alcohol licenses to have ingestible products that state CBD on the label. Spoke at length with a Lazy Acres manager about it. Might need to modify the ingestible labels to Hemp instead stating CBD. you can still buy soft gels and oils from outlets that do not have alcohol licenses. California ABC watching this closely.
Nice news Mux!
Garden of Life was bought by that little company that goes by the name of Nestle back in 2017.
Search a Sprouts store. GOL has over 150 items in each Sprouts.
https://shop.sprouts.com/search?search_term=garden%20of%20life